Navigation Links
Pfizer supports open access publishing for researchers in low-income countries
Date:5/5/2009

Today, Pfizer announced an agreement with BioMed Central to launch an open access waiver fund which will support automatic waivers of publication fees for authors from low-income countries.

Thanks to the open access waiver fund, researchers in low-income countries can publish research articles in BioMed Central's open access journals without the need to pay a publication fee.

Speaking of the agreement Dr Jack Watters, Vice President, Pfizer External Medical Affairs said "Pfizer's support for open access publishing is driven by a recognition of the wide benefits of global access to the latest research results, and the crucial role that open access journals can play in the communication of those results. In addition, we feel that it is critically important that the benefits of scientific publication are extended to all scientists who do quality research, and that providing this access will promote much-needed recognition of research conducted in developing countries.

Matthew Cockerill, BioMed Central's Managing Director, commented: "Researchers working in low-income countries have been strong supporters of open access publishing. Many of BioMed Central's most successful journals such as Malaria Journal and BMC Public Health, focus on issues of strong relevance to developing countries and publish many articles from these countries. BioMed Central's policy of automatic waivers for low-income countries ensures that researchers based in these countries will face no financial barrier to publishing and sharing their work in a way that makes it globally accessible."


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-020-319-22216
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. Pfizer inks global license to Genomatix Software and databases
2. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
3. $10 million Simons Foundation gift supports new initiative with Institute for Advanced Study
4. Lancet study supports new, highly effective treatment for blood disorder
5. Research supports toxoplasmosis link to schizophrenia
6. VCU survey: US public supports genetic research, testing and government spending on research
7. Synthetic virus supports a bat origin for SARS
8. The MDS foundation supports vidazas recommendation for European approval
9. The MDS Foundation supports the FDAs decision to expand vidaza label to include survival data
10. New book further supports controversial theory of Man the Hunted
11. Grant supports emerging field of massive data analysis and visual analytics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... 20, 2016  As part of its longstanding mission to ... genetics company, recently released its latest children,s book, titled ... focuses on the topics of inheritance and variation of traits ... taught in elementary school classrooms in the US. ... illustrator Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/16/2016)... --  IdentyTechSolutions America LLC , a leading provider ... a cutting-edge manufacturer of software and hardware security ... integrated solutions that comprise IDT biometric readers and ... IdentyTech,s customers with combined physical identification and anti-tailgating ... theft. "We are proud to use ...
(Date:12/15/2016)... 2016 ... Research and Markets has announced the addition of the ... The report forecasts the global military biometrics market to grow at ... report has been prepared based on an in-depth market analysis with inputs ... prospects over the coming years. The report also includes a discussion of ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... IRVING, Texas , Jan. 18, 2017 /PRNewswire/ ... science, and the Lustgarten Foundation, the largest private ... support a clinical trial evaluating the impact of ... is providing clinical trial enrollment services to identify ... and facilitate communication between treating physicians and study ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... (RF) to its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 ... base. Each VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” ...
(Date:1/17/2017)... Jan. 17, 2017  An international team of ... and St. Boniface Hospital Albrechtsen Research Centre/University of ... an unmet health need affecting nearly one in ... Clinical Investigation, their results identify small molecule drugs ... reverse neuronal injury in animal models of metabolic, ...
(Date:1/17/2017)... 2017   Pulmatrix, Inc . (NASDAQ: ... inhaled therapies to address serious pulmonary diseases, today announced ... the lungs of CF patients, PUR1900, has been designated ... U.S. Food & Drug Administration. Under ... the development of novel drugs against important pathogens, Pulmatrix ...
Breaking Biology Technology: